Skip To Main Content
Andrea Baragetti on Muck Rack

Andrea Baragetti

As seen in: Nature, British Pharmacological Society, Frontiers, MDPI, Taylor & Francis Online, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andrea

Contact Andrea, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Glucocorticoid signalling dysregulation and immune cell adaptation in Anorexia Nervosa

|
By Francesca Mottarlini, Andrea Baragetti, Beatrice Rizzi, Sofia Taddini, Anna Chiara Cigognini, Sara Bertelli, Armando D’Agostino, Fabrizia Bonacina, Giuseppe Danilo Norata, Fabio Fumagalli, Lucia Caffino, Susanna Parolaro, Francesca Vairano
| Nature Verified
Abstract Anorexia Nervosa (AN) is a neuropsychiatric disorder marked by compulsive weight-loss and hyperactivity, with poorly understood underlying mechanisms and limited treatment outcomes. Here we show that women with AN, at the first medical evaluation, exhibit hyperactivity and hypercortisolemia, together with a reduced immune cell count yet paradoxically showing increased levels of cell activation.
Open in Who Shared Issue with article?

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes

|
By Andrea Baragetti, Giuseppe Danilo Norata
| British Pharmacological Society
Filename Description bph70483-sup-0001-Table_S1.docxWord 2007 document , 23.5 KB Table S1.
Open in Who Shared Issue with article?

Targeting PCSK9 beyond the liver: evidence from experimental and clinical studies

|
By Andrea Baragetti, Giuseppe Danilo Norata
| Taylor & Francis Online
ABSTRACT Introduction PCSK9 has been widely studied as a target for lipid-lowering as its inhibition increases LDLR recycling on the surface of hepatocytes, which promotes the catabolism of LDL particles. PCSK9 can be synthesized in extra-hepatic tissues, including in the brain, the pancreas, and the heart, and in immune cells.
Open in Who Shared Issue with article?
See all 7 articles